VA

VR Adviser Portfolio holdings

AUM $1.33B
This Quarter Return
+23.52%
1 Year Return
+6.92%
3 Year Return
+862.77%
5 Year Return
+1,580.48%
10 Year Return
–
AUM
$625M
AUM Growth
+$625M
Cap. Flow
+$66.7M
Cap. Flow %
10.67%
Top 10 Hldgs %
69.45%
Holding
35
New
10
Increased
5
Reduced
4
Closed
5

Top Buys

1
FDMT icon
4D Molecular Therapeutics
FDMT
$54.2M
2
DYN icon
Dyne Therapeutics
DYN
$24.5M
3
PHVS icon
Pharvaris
PHVS
$20.1M
4
RYTM icon
Rhythm Pharmaceuticals
RYTM
$18M
5
ORIC icon
Oric Pharmaceuticals
ORIC
$16.6M

Top Sells

1
DICE
DICE Therapeutics, Inc. Common Stock
DICE
$23.5M
2
PLRX icon
Pliant Therapeutics
PLRX
$20.7M
3
JBIO
Jade Biosciences, Inc. Common Stock
JBIO
$16.8M
4
VECT
VectivBio Holding AG Ordinary Shares
VECT
$15.9M
5
AMAM
Ambrx Biopharma, Inc. Common Stock
AMAM
$13.4M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SYRE icon
26
Spyre Therapeutics
SYRE
$1.02B
$2.86M 0.46%
+6,343,221
New +$2.86M
BDTX icon
27
Black Diamond Therapeutics
BDTX
$164M
$1.79M 0.29%
+353,629
New +$1.79M
RLYB icon
28
Rallybio
RLYB
$24.1M
$1.52M 0.24%
268,532
– –
AFMD
29
DELISTED
Affimed
AFMD
$855K 0.14%
1,428,571
– –
AVTX icon
30
Avalo Therapeutics
AVTX
$139M
$444K 0.07%
1,250,000
+250,000
+25% +$88.7K
VECT
31
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
– –
-1,866,000
Closed -$15.9M
DICE
32
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
– –
-819,000
Closed -$23.5M
FULC icon
33
Fulcrum Therapeutics
FULC
$353M
– –
-1,307,094
Closed -$3.73M
JBIO
34
Jade Biosciences, Inc. Common Stock
JBIO
$245M
– –
-833,927
Closed -$16.8M
ANNX icon
35
Annexon
ANNX
$225M
– –
-3,220,050
Closed -$12.4M
1
2